Search
-
What Worries the World - July 2017
New global poll finds unemployment remains the top issue around the world. What Worries the World study finds the majority of people across 26 countries think that their country is on the wrong track — Mexico, South Africa, Brazil, Italy and Hungary being the most concerned.
-
Designing a ‘Smarter’ Mystery Shopping Program
Seven Steps to Success - Countless research studies show that brands which put the customer first and deliver a superior experience relative to their competition, achieve greater customer loyalty, higher profits and better returns for shareholders.
-
The Global Reputation Centre - FAQs
This in-depth publication from the Ipsos Public Affairs team provides answer to some frequently asked questions about corporate reputation, CSR, and how we help clients to avoid crises.
-
Brazil Pulse - 85% of Brazilians Consider the Michel Temer's Administration bad - July 2017
The country is still heading in the wrong direction for 95% of Brazilians, repeating last month’s result. This decline of the confidence in Brazil lifted off in January 2015 and stabilized at extremely high levels since then.
-
The Economic Pulse of the World - July 2017
The average global economic assessment of national economies surveyed in 26 countries is down two points with 43% of global citizens rating their national economies as ‘good’.
-
Taking Responsibility - Ipsos in Japan Puts CSR Front and Centre
Ipsos Japan is putting CSR at the top of the agenda with the creation of their new CSR Ambassadors group.
-
A Way To Get Away
Taking vacation is a way to get away for a few days from the fast-paced modern world. But do we take all vacation days available to us? Do we fully disconnect when we are away? A new Ipsos Global @dvisor poll reveals opinions of citizens in 25 countries around the world about taking time off.
-
Ipsos Healthcare adds Hidradenitis Suppurativa (HS) to Global Therapy Monitor Portfolio
Ipsos Healthcare, the global healthcare division of Ipsos, has launched the Hidradenitis Suppurativa (HS) Therapy Monitor in the EU5. The HS Monitor, part of Ipsos’ Autoimmune Real World Evidence portfolio, launched in the EU5 in Q2 of 2017, with plans to extend to other markets.
-
2017 US Politics - Trump’s Highest Issue Approval Rating Remains Dealing with ISIS/ISIL (July 26)
In the latest Reuters/Ipsos Core Political, 27% of Americans say healthcare is their top priority.